Sutureless aspiration cutter biopsy is beneficial in diagnosing ocular cancers

Article

Sutureless aspiration cutter biopsy can be used to diagnose ocular cancers such as orbital lymphoma.

Sutureless aspiration cutter biopsy can be used to diagnose ocular cancers such as orbital lymphoma, according to a paper featured in the European Journal of Ophthalmology.

Dr Paul T. Finger et al., New York Eye Cancer Center, New York, USA, included three patients in the study with orbital adnexal tumours. Each participant underwent orbital biopsy via a 3 mm incision into the eyelid or conjunctival fornix.

A bimanual technique was used to introduce standard aspiration cutters into the anterior and posterior orbital tumours. The team conducted cytopathology, histopathology and immunohistochemical analysis on all three patients.

The diagnoses were orbital lymphoma, metastatic endometrial adenocarcinoma, and metastatic prostate cancer, with the 20G aspiration cutter yielding the most tissue. The small incisions did not require any sutures.

The technique was strongly linked to fine needle aspiration biopsy, controlled aspiration and enclosed mechanical cutting.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.